CytomX Therapeutics, Inc. (CTMX) vs OrthoPediatrics Corp. (KIDS)
A side-by-side comparison of CytomX Therapeutics, Inc. and OrthoPediatrics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTMX
CytomX Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
KIDS
OrthoPediatrics Corp.
$22.70HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CTMX vs KIDS
growth of $100 · dividends reinvested · last 9yCTMX -88.0% (-21.0%/yr)KIDS +19.1% (+2.0%/yr)KIDS compounded faster over this window
Log scale — wide-divergence pair
CTMX KIDS
CTMX vs KIDS: by the numbers
- •KIDS is the larger company ($583M vs $557M market cap).
- •Both run net losses; KIDS's is the smaller (-15.72% vs -435.21% net margin).
- •KIDS grew revenue faster over the past five years (23.14% vs 2.18% CAGR).
Metrics side by side
Valuation
| Metric | CTMX | KIDS |
|---|---|---|
| P/S ratio | 30.46 | 2.31 |
| P/B ratio | 1.85 | 1.70 |
Profitability
| Metric | CTMX | KIDS |
|---|---|---|
| Gross margin | 98.63% | 73.65% |
| Operating margin | -29.35% | -9.01% |
| Net margin | -435.21% | -15.72% |
| ROE | -26.37% | -11.56% |
| ROIC | -25.42% | -4.97% |
Growth (annualized)
| Metric | CTMX | KIDS |
|---|---|---|
| Revenue CAGR (5Y) | 2.18% | 23.14% |
| Total return CAGR (5Y) | -12.01% | -18.40% |
Frequently asked
- Which has grown faster, CTMX or KIDS?
- Over the past five years, KIDS grew revenue faster — CTMX at a 2.18% CAGR versus KIDS at 23.14%.
- How have CTMX and KIDS total returns compared?
- Over the past 5 years, CTMX delivered -12.01% and KIDS delivered -18.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CytomX Therapeutics ROEOrthoPediatrics ROECytomX Therapeutics operating marginOrthoPediatrics operating marginCytomX Therapeutics revenue growthOrthoPediatrics revenue growthCytomX Therapeutics free cash flowOrthoPediatrics free cash flow
CytomX Therapeutics & OrthoPediatrics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.